AGRITEK HLDGS INC COM USD0.0001 (OTCMKTS:AGTK) Is A Potential Runner

AGRITEK HLDGS INC COM USD0.0001 (OTCMKTS:AGTK) just put out the news that it has completed the filing of its quarterly reports and has returned to fully reporting and compliant trading status. The company hasn’t really moved on the news, despite having taken a hit over the last few quarters on the back of its non compliance.This isn’t the first time this year that the company has put out an announcement like this, of course – it did the same in May after a period of non compliance. It didn’t move much then, either, but this time around, there's a difference. This time, Agritek has spent its period of non compliance developing its operations, and has made a few key announcements to that end recently. These developments should add value as we head into the close of 2016 and beyond, and with a foundation of filing compliance, this value could be substantial.Here's what we are thinking.First up, a brief introduction to the company. Agritek is a self proclaimed medical marijuana pioneer, but this is a little misleading. It doesn’t actually handle any marijuana products (again, not yet, but we'll touch on this shortly), but instead creates and distributes technology that underpins grow framework – greenhouses, real estate, that sort of thing. Through a subsidiary, it rents out land leases of up to 5 acres for grow use, and fit out the property with everything required for growth and harvest.That's the legacy and continuing operations, but now it seems that the company is shifting towards a more hands on approach. Specifically, it's got a patent pending hemp product, which it announced at the end of November, billed as being created using – and to quote – the only feasible method of combining hemp oil with a gum in a product of this type.Now, this goes against this statement:

"(the company) does not directly grow, harvest, or distribute or sell cannabis or any substances that violate or contravene United States law or the Controlled Substances Act, nor does it intend to do so in the future."

We assume its referring to the violation of the US CSA as opposed to the distribution of cannabis, since this hemp oil product is a CBD product, so technically it falls under controlled substances. Anyway, that's not really important to our thesis.So we've got a company that is fully compliant, working in the grow space, and shifting in to the hemp product distribution arena. It's moving in to Puerto Rico, by way of a fresh office location, and it's building out its portfolio by way of its wellness product range.All this is ongoing, and – and here's what we're watching as the next major upside catalyst – the company is setting up to uplist on to a major exchange. We're fully aware that, right now, the ongoing operations are early stage, and that as things stand, it's not generating any revenues. However, this is primarily due to a management pivot (its previous CEO resigned and started working for a competitor, the latter of which Agritek is now suing for royalties on patented product sales) and we don't think it's representative of the company's prospects moving forward. However, when the uplisting hits (and if Agritek can get its shop in order, something it's made a big step towards doing with this compliance and filing box checked), the news alone is going to draw speculative volume towards the stock. Marijuana is hot right now, and companies across the space are picking up strength on tedious links to recreational expansion. Agritek has plenty of these links, and while the numbers that underpin the claims aren’t exactly supportive of them, there looks to be plenty of upside on offer by becoming one of the first entities with a cannabis focus to hit a major exchange.Not a buy and hold, but as a potential runner, we like it.We will be updating our subscribers as soon as we know more. For the latest updates on AGTK, sign up below!Disclosure: We have no position in AGTK and have not been compensated for this article.